FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

773832000: Antiglaucoma therapeutic role (role)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Jan 2019. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
3726718011 Antiglaucoma therapeutic role en Synonym Active Entire term case insensitive SNOMED CT core module
3726719015 Antiglaucoma therapeutic role (role) en Fully specified name Active Entire term case insensitive SNOMED CT core module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Antiglaucoma therapeutic role Is a Therapeutic role true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing phenylephrine in ocular dose form (medicinal product form) Plays role True Antiglaucoma therapeutic role Inferred relationship Existential restriction modifier
Product containing only apraclonidine in ocular dose form (medicinal product form) Plays role True Antiglaucoma therapeutic role Inferred relationship Existential restriction modifier
Product containing pilocarpine in ocular dose form (medicinal product form) Plays role True Antiglaucoma therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely apraclonidine (as apraclonidine hydrochloride) 5 milligram/1 milliliter conventional release eye drops Plays role True Antiglaucoma therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely epinephrine 10 milligram/1 milliliter conventional release eye drops Plays role True Antiglaucoma therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely pilocarpine hydrochloride 5 milligram/1 milliliter conventional release eye drops Plays role True Antiglaucoma therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely phenylephrine hydrochloride 25 milligram/1 gram conventional release eye drops Plays role True Antiglaucoma therapeutic role Inferred relationship Existential restriction modifier
Product containing epinephrine in ocular dose form (medicinal product form) Plays role True Antiglaucoma therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely pilocarpine hydrochloride 10 milligram/1 milliliter conventional release eye drops Plays role True Antiglaucoma therapeutic role Inferred relationship Existential restriction modifier
Product containing acetazolamide in oral dose form (medicinal product form) Plays role True Antiglaucoma therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely pilocarpine hydrochloride 20 milligram/1 milliliter conventional release eye drops Plays role True Antiglaucoma therapeutic role Inferred relationship Existential restriction modifier
Product containing apraclonidine in ocular dose form (medicinal product form) Plays role True Antiglaucoma therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely epinephrine 5 milligram/1 milliliter and guanethidine monosulfate 30 milligram/1 milliliter conventional release eye drops Plays role True Antiglaucoma therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely pilocarpine hydrochloride 40 milligram/1 milliliter conventional release eye drops Plays role True Antiglaucoma therapeutic role Inferred relationship Existential restriction modifier
Product containing physostigmine in ocular dose form (medicinal product form) Plays role True Antiglaucoma therapeutic role Inferred relationship Existential restriction modifier
Product containing only netarsudil in ocular dose form (medicinal product form) Plays role True Antiglaucoma therapeutic role Inferred relationship Existential restriction modifier
Product containing netarsudil in ocular dose form (medicinal product form) Plays role True Antiglaucoma therapeutic role Inferred relationship Existential restriction modifier
Product containing only dapiprazole in ocular dose form (medicinal product form) Plays role True Antiglaucoma therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely mannitol 200 milligram/1 milliliter conventional release solution for infusion (clinical drug) Plays role True Antiglaucoma therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely mannitol 100 milligram/1 milliliter conventional release solution for infusion (clinical drug) Plays role True Antiglaucoma therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely brimonidine tartrate 1.5 milligram/1 milliliter conventional release eye solution (clinical drug) Plays role True Antiglaucoma therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely pilocarpine hydrochloride 80 milligram/1 milliliter conventional release eye solution (clinical drug) Plays role True Antiglaucoma therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely cyclopentolate hydrochloride 2 milligram/1 milliliter and phenylephrine hydrochloride 10 milligram/1 milliliter conventional release eye solution (clinical drug) Plays role True Antiglaucoma therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely phenylephrine hydrochloride 100 milligram/1 milliliter conventional release eye solution (clinical drug) Plays role True Antiglaucoma therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely pilocarpine hydrochloride 2.5 milligram/1 milliliter conventional release eye solution (clinical drug) Plays role True Antiglaucoma therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely unoprostone isopropyl 1.5 milligram/1 milliliter conventional release eye solution (clinical drug) Plays role True Antiglaucoma therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely brimonidine tartrate 1 milligram/1 milliliter conventional release eye solution (clinical drug) Plays role True Antiglaucoma therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely pilocarpine hydrochloride 100 milligram/1 milliliter conventional release eye solution (clinical drug) Plays role True Antiglaucoma therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely epinephrine 5 milligram/1 milliliter conventional release eye solution (clinical drug) Plays role True Antiglaucoma therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely acetazolamide 500 milligram/1 vial powder for conventional release solution for injection (clinical drug) Plays role True Antiglaucoma therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely dipivefrine hydrochloride 1 milligram/1 milliliter conventional release eye solution (clinical drug) Plays role True Antiglaucoma therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely physostigmine sulfate 10 milligram/1 milliliter conventional release eye solution (clinical drug) Plays role True Antiglaucoma therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely physostigmine salicylate 2.5 milligram/1 milliliter and pilocarpine hydrochloride 20 milligram/1 milliliter conventional release eye solution (clinical drug) Plays role True Antiglaucoma therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely phenylephrine hydrochloride 25 milligram/1 milliliter conventional release eye solution (clinical drug) Plays role True Antiglaucoma therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely physostigmine salicylate 2.5 milligram/1 milliliter and pilocarpine hydrochloride 40 milligram/1 milliliter conventional release eye solution (clinical drug) Plays role True Antiglaucoma therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely physostigmine salicylate 5 milligram/1 milliliter and pilocarpine hydrochloride 40 milligram/1 milliliter conventional release eye solution (clinical drug) Plays role True Antiglaucoma therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely ecothiopate iodide 300 microgram/1 milliliter conventional release eye solution (clinical drug) Plays role True Antiglaucoma therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely ecothiopate iodide 600 microgram/1 milliliter conventional release eye solution (clinical drug) Plays role True Antiglaucoma therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely physostigmine salicylate 2.5 milligram/1 milliliter conventional release eye solution (clinical drug) Plays role True Antiglaucoma therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely ecothiopate iodide 2.5 milligram/1 milliliter conventional release eye solution (clinical drug) Plays role True Antiglaucoma therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely physostigmine salicylate 5 milligram/1 milliliter conventional release eye solution (clinical drug) Plays role True Antiglaucoma therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely ecothiopate iodide 1.25 milligram/1 milliliter conventional release eye solution (clinical drug) Plays role True Antiglaucoma therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely epinephrine 1 milligram/1 milliliter conventional release eye solution (clinical drug) Plays role True Antiglaucoma therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely epinephrine 2.5 milligram/1 milliliter conventional release eye solution (clinical drug) Plays role True Antiglaucoma therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely ecothiopate (as ecothiopate iodide) 1.25 milligram/1 milliliter conventional release eye solution (clinical drug) Plays role True Antiglaucoma therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely epinephrine (as epinephrine bitartrate) 500 microgram/1 milliliter and guanethidine 2.5 milligram/1 milliliter conventional release eye solution (clinical drug) Plays role True Antiglaucoma therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely epinephrine (as epinephrine bitartrate) 1 milligram/1 milliliter and guanethidine 5 milligram/1 milliliter conventional release eye solution (clinical drug) Plays role True Antiglaucoma therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely epinephrine (as epinephrine bitartrate) 5 milligram/1 milliliter and guanethidine 10 milligram/1 milliliter conventional release eye solution (clinical drug) Plays role True Antiglaucoma therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely levobetaxolol 5 milligram/1 milliliter conventional release eye suspension (clinical drug) Plays role True Antiglaucoma therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely mannitol 100 milligram/1 milliliter conventional release solution for injection (clinical drug) Plays role True Antiglaucoma therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely carbachol 10 milligram/1 milliliter conventional release eye solution (clinical drug) Plays role True Antiglaucoma therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely carbachol 15 milligram/1 milliliter conventional release eye solution (clinical drug) Plays role True Antiglaucoma therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely epinephrine (as epinephrine bitartrate) 500 microgram/1 milliliter conventional release eye solution (clinical drug) Plays role True Antiglaucoma therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely betaxolol hydrochloride 2.5 milligram/1 milliliter conventional release eye suspension (clinical drug) Plays role False Antiglaucoma therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely apraclonidine (as apraclonidine hydrochloride) 10 milligram/1 milliliter conventional release eye solution (clinical drug) Plays role False Antiglaucoma therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely levobunolol hydrochloride 5 milligram/1 milliliter conventional release eye solution (clinical drug) Plays role True Antiglaucoma therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely cocaine (as cocaine hydrochloride) 50 milligram/1 milliliter and epinephrine 200 microgram/1 milliliter conventional release eye solution (clinical drug) Plays role True Antiglaucoma therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely timolol (as timolol maleate) 2.5 milligram/1 milliliter conventional release eye solution (clinical drug) Plays role False Antiglaucoma therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely timolol (as timolol maleate) 5 milligram/1 milliliter conventional release eye solution (clinical drug) Plays role False Antiglaucoma therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely brimonidine tartrate 2 milligram/1 milliliter and timolol 5 milligram/1 milliliter conventional release eye solution (clinical drug) Plays role True Antiglaucoma therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely metipranolol 1 milligram/1 milliliter conventional release eye solution (clinical drug) Plays role True Antiglaucoma therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely metipranolol 3 milligram/1 milliliter conventional release eye solution (clinical drug) Plays role True Antiglaucoma therapeutic role Inferred relationship Existential restriction modifier
Product containing physostigmine and pilocarpine in ocular dose form (medicinal product form) Plays role True Antiglaucoma therapeutic role Inferred relationship Existential restriction modifier
Product containing brimonidine and timolol in ocular dose form (medicinal product form) Plays role True Antiglaucoma therapeutic role Inferred relationship Existential restriction modifier
Product containing cocaine and epinephrine in ocular dose form (medicinal product form) Plays role True Antiglaucoma therapeutic role Inferred relationship Existential restriction modifier
Product containing cyclopentolate and phenylephrine in ocular dose form (medicinal product form) Plays role True Antiglaucoma therapeutic role Inferred relationship Existential restriction modifier
Product containing only brimonidine and timolol in ocular dose form (medicinal product form) Plays role True Antiglaucoma therapeutic role Inferred relationship Existential restriction modifier
Product containing only cocaine and epinephrine in ocular dose form (medicinal product form) Plays role True Antiglaucoma therapeutic role Inferred relationship Existential restriction modifier
Product containing only cyclopentolate and phenylephrine in ocular dose form (medicinal product form) Plays role True Antiglaucoma therapeutic role Inferred relationship Existential restriction modifier
Product containing only physostigmine and pilocarpine in ocular dose form (medicinal product form) Plays role True Antiglaucoma therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely pilocarpine nitrate 20 milligram/1 milliliter conventional release solution for eye drops (clinical drug) Plays role False Antiglaucoma therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely pilocarpine nitrate 20 milligram/1 milliliter conventional release eye drops (clinical drug) Plays role True Antiglaucoma therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely mannitol 200 milligram/1 milliliter conventional release solution for injection (clinical drug) Plays role True Antiglaucoma therapeutic role Inferred relationship Existential restriction modifier
Product containing suramin in parenteral dose form (medicinal product form) Plays role False Antiglaucoma therapeutic role Inferred relationship Existential restriction modifier
Product containing only suramin in parenteral dose form (medicinal product form) Plays role False Antiglaucoma therapeutic role Inferred relationship Existential restriction modifier
Product containing only timolol and travoprost in ocular dose form (medicinal product form) Plays role True Antiglaucoma therapeutic role Inferred relationship Existential restriction modifier
Product containing timolol and travoprost in ocular dose form (medicinal product form) Plays role True Antiglaucoma therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely timolol (as timolol maleate) 5 milligram/1 milliliter and travoprost 40 microgram/1 milliliter conventional release eye drops (clinical drug) Plays role True Antiglaucoma therapeutic role Inferred relationship Existential restriction modifier
Product containing bimatoprost and timolol in ocular dose form (medicinal product form) Plays role True Antiglaucoma therapeutic role Inferred relationship Existential restriction modifier
Product containing only bimatoprost and timolol in ocular dose form (medicinal product form) Plays role True Antiglaucoma therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely bimatoprost 300 microgram/1 milliliter and timolol (as timolol maleate) 5 milligram/1 milliliter conventional release eye drops (clinical drug) Plays role True Antiglaucoma therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely bimatoprost 100 microgram/1 milliliter conventional release eye drops (clinical drug) Plays role True Antiglaucoma therapeutic role Inferred relationship Existential restriction modifier
Acetazolamide Plays role True Antiglaucoma therapeutic role Inferred relationship Existential restriction modifier
Product containing acetazolamide Plays role True Antiglaucoma therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely apraclonidine (as apraclonidine hydrochloride) 10 milligram/1 milliliter conventional release eye drops (clinical drug) Plays role True Antiglaucoma therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely mannitol 200 milligram/1 milliliter conventional release solution for infusion and/or injection (clinical drug) Plays role True Antiglaucoma therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely mannitol 100 milligram/1 milliliter conventional release solution for infusion and/or injection (clinical drug) Plays role True Antiglaucoma therapeutic role Inferred relationship Existential restriction modifier
Acetazolamide 175mg/5ml oral solution Plays role True Antiglaucoma therapeutic role Inferred relationship Existential restriction modifier
Acetazolamide 150mg/5ml oral suspension Plays role True Antiglaucoma therapeutic role Inferred relationship Existential restriction modifier
Acetazolamide 200mg/5ml oral suspension Plays role True Antiglaucoma therapeutic role Inferred relationship Existential restriction modifier
Acetazolamide 350mg/5ml oral solution Plays role True Antiglaucoma therapeutic role Inferred relationship Existential restriction modifier
Acetazolamide 18mg/5ml oral solution Plays role True Antiglaucoma therapeutic role Inferred relationship Existential restriction modifier
Acetazolamide 400mg/5ml oral solution Plays role True Antiglaucoma therapeutic role Inferred relationship Existential restriction modifier
Acetazolamide 40mg/5ml oral solution Plays role True Antiglaucoma therapeutic role Inferred relationship Existential restriction modifier
Acetazolamide 5mg/5ml oral solution Plays role True Antiglaucoma therapeutic role Inferred relationship Existential restriction modifier
Acetazolamide 40mg/5ml oral suspension Plays role True Antiglaucoma therapeutic role Inferred relationship Existential restriction modifier
Acetazolamide 500mg/5ml oral solution Plays role True Antiglaucoma therapeutic role Inferred relationship Existential restriction modifier
Acetazolamide 425mg/5ml oral suspension Plays role True Antiglaucoma therapeutic role Inferred relationship Existential restriction modifier
Acetazolamide 62.5mg/5ml oral solution Plays role True Antiglaucoma therapeutic role Inferred relationship Existential restriction modifier
Acetazolamide 20mg/5ml oral solution Plays role True Antiglaucoma therapeutic role Inferred relationship Existential restriction modifier
Acetazolamide 150mg/5ml oral solution Plays role True Antiglaucoma therapeutic role Inferred relationship Existential restriction modifier

Start Page 2 of 3 End

This concept is not in any reference sets

Back to Start